Araştırma özeti
Aşağıdaki metin kaynak makalenin lisansı doğrulanmış orijinal özetidir. cc by
BackgroundParkinson's disease (PD) and cutaneous melanoma show epidemiological co-occurrence, but their shared genetic architecture remains unclear METHODS: We combined bidirectional time-dependent cox regression in the UK biobank (N ≈ 500,000) with a multi-layered genomic analysis using large-scale PD and melanoma GWAS summary statistics (N = 745,746). Genetic analyses included linkage disequilibrium score regression (LDSC), bidirectional Mendelian randomization (MR), PLACO, LAVA, and Bayesian colocalization RESULTS: Melanoma was associated with increased subsequent PD risk (HR = 1.62, 95% CI: 1.18-2.23), whereas the reverse PD-to-melanoma analysis was not statistically significant and was limited by low event counts. LDSC showed a modest positive genetic correlation (rg = 0.181, P = 0.04), while MR provided no evidence of bidirectional causality. PLACO identified 134 pleiotropic SNPs across 25 gene loci, including SOX6, the GDF5-GSS-EDEM2 cluster, and immune-related loci at 17q21.32. LAVA identified 17 locally correlated loci, with antagonistic effects predominating (11/17, 64.7%). Bayesian colocalization highlighted SOX6 as the strongest shared-signal locus (PP·H4 = 0.904; PP·H3 = 0.054) CONCLUSIONS: PD-melanoma co-occurrence is supported by shared but heterogeneous genetic architecture rather than bidirectional causality. Antagonistic local effects may partially offset genome-wide correlation, while SOX6 represents a prioritized colocalized candidate locus linking dopaminergic neuron vulnerability and melanocytic biology.
Bilimsel değerlendirme
Araştırma sorusu
Sorunun kapsamı orijinal çalışma üzerinden değerlendirilir.
Yöntem ve örneklem
Çalışma tasarımı ve örneklem için kaynak makaleyi kontrol edin.
Temel bulgular
Bu kayıt için editoryal olarak onaylanmış bulgu özeti henüz yayımlanmadı.
Sınırlılıklar
Sonuçların genellenebilirliği, yanlılık ve klinik anlamı ayrıca incelenmelidir.
Bibliyografik veriden yöntem, örneklem veya klinik sonuç çıkarımı yapılmaz.